Concord Drugs BSE
33.81 00.00 (1.04%) 
To view real-time data of Concord Drugs and trade with industry first features, Login or Open Free Demat Account.
Concord Drugs Share Price Insights
Concord Drugs share price as of last closing was 33.81 on . As on date, the market capitalization of the company is Rs. 30.54 Crores and the book value of the same is Rs 34.97 Crores. As per NSE data, in last traded details the quantity of shares traded for Concord Drugs were . For the last 1 year period, Concord Drugs share price saw 1-year high of 41.80 and 1-year low of 24.80. If you would have invested in Concord Drugs share,... based on its share price your 1-year return on same would be 3.19%, on a 3-year investment period the return would be 102.49% and on a 5 year investment period the return would be 44.04%. In the financial year -, Concord Drugs registered a net income of 0.00 Cr. The company’s EPS stood at 0.00 while P/E Ratio stood at 25.68. While, analysing Share Price of a company is crucial, it is equally important to look at the Stock Performance, Fundamental Analysis, Financial Statements, Technical Analysis and Similar Stocks Comparision. It gives a sense of whether the company is growing, stable or deteriorating.
Stock Performance
Markets Today
| High | 35.80 |
| Open at | 35.80 |
| Volumes | 81 |
| Lower Circuit | 2100.00 |
| Low | 34.04 |
| Prev Close | 33.81 |
| Avg Price | 2205.85 |
| Upper Circuit | 2400.00 |
Last Traded Details
| Quantity | 92,923 |
| Time | 13:46:05 |
Historical Performance
| 1-Year High | 41.80 |
| 3-Year High | 44.95 |
| 5-Year High | 44.95 |
| 1-Year Low | 24.80 |
| 3-Year Low | 16.40 |
| 5-Year Low | 11.68 |
1-Year Performance Indicator
42.15%
down side
up side
25.09%
Concord Drugs Fundamentals
Company Valuation
| Market Cap (₹ Cr.) | 30.54 |
| Book Value (₹) | 34.97 |
| Face Value (₹) | 10.00 |
| P/E ratio | 25.68 |
| Dividend Yield | 0.0 % |
Company Financials
Income Statements
| Financial Year | FY - |
| All Expenditure (Cr) | 0.00 |
| Operating Profit (Cr) | 0.00 |
| EBIDTA (Cr) | 0.00 |
| Profit Before Tax (Cr) | 0.00 |
| Tax (Cr) | 0.00 |
| Net Income (Cr) | 0.00 |
| EPS (Cr) | 0.00 |
| DPS (Cr) | 0.00 |
Concord Drugs Investment Returns
In Short term
In Long term
| 1 Week | -0.14% |
| 1 Month | -8.44% |
| 3 Months | 26.70% |
| 6 Months | 29.32% |
| 9 Months | 9.50% |
| 1 Year | 3.19% |
| 2 Years | 25.42% |
| 3 Years | 102.49% |
| 4 Years | 106.69% |
| 5 Years | 44.04% |
Stocks Similar To Concord Drugs
Frequently Asked Questions on Concord Drugs Share
Concord Drugs share price as of today is Rs. . The company has a market capitalization of Rs. 30.54 with a P/E ratio of 25.68. Over the past 1 year, Concord Drugs’s share price has moved by 3.19% while the 5-year performance of the stock stands at 44.04%. You’d also be interested to know that Concord Drugs's share price has a 1-year low of ₹ 24.80 and a 1-year high of ₹ 41.80.
The Concord Drugs share hit a 1-year low of Rs. 24.80 and a 1-year high of Rs. 41.80. The current market capitalization of Concord Drugs is Rs. 30.54. While past performance does not guarantee future performance, the past 1-year return of Concord Drugs share was 3.19% while the 5-year return was 44.04%.
Concord Drugs share price has moved by 3.19% in the past 1 year. During the same time, the stock hit a 1-year high of Rs. 41.80 and a 1-year low of Rs. 24.80. As far as the long-term trend is concerned, the 5-year performance of Concord Drugs share stands at 44.04%
Concord Drugs has a market capitalization of Rs. 30.54 as of today, while the share price stands at . The market cap has moved by 3.19% in the past year and 44.04% in the past 5 years.
As a stock investor, you’d be interested in knowing that Concord Drugs share price has a P/E ratio of 25.68 as of today. Along with the P/E ratio, the book value of Concord Drugs’s stock is Rs. 34.97
Domestic Institutional Investors (DIIs) have a share in Concord Drugs whereas Foreign Institutional Investors (FIIs) hold . The split between DIIs and FIIs is a crucial metric that stock investors track to gauge the market sentiment around the stock. The company’s promoters own of Concord Drugs while non-promoters have a stake.
You can buy Concord Drugs shares using the Dhan Trading App or Web Trading Platform. Follow these steps to get started:
- Open free demat account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Concord Drugs share
- Tap on “Buy”
If you have little money and want to buy Concord Drugs stocks,Margin Trading Facility (MTF) is just the thing you need! MTF allows you to buy more with less. In fact, you can buy up to 4x more, which means you pay 25% and Dhan pays 75% for buying Concord Drugs stocks.
